Evaluation of the Efficacy of "Lifespan Integration" (LI) Therapy in Patients With Complex Post-Traumatic Stress Disorder

Last updated: August 1, 2024
Sponsor: Centre Hospitalier St Anne
Overall Status: Active - Recruiting

Phase

N/A

Condition

Tourette's Syndrome

Post-traumatic Stress Disorders

Kleptomania

Treatment

Lifespan Integration Therapy (LI)

Clinical Study ID

NCT06535243
D21-P019
  • Ages > 18
  • All Genders

Study Summary

The study aims to evaluate the efficacy of a relatively new type of psychotherapy called Lifespan Integration (LI) in patients suffering of complex PTSD

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients diagnosed with complex PTSD

  • French speaking

  • first time following an LI type of therapy

  • psychotropic treatment is allowed

Exclusion

Exclusion Criteria:

  • no other parallel psychotherapy is accepted (if the patient underwent recently anyother type of psychotherapy, a "wash out " period of minimum 4 weeks is required )

  • no active manic episode at the time of inclusion

  • no active psychotic episode at the time of inclusion

  • no chronic psychotic disorder diagnosis

  • no autistic spectrum disorder diagnosis ,

  • no intellectual deficit

Study Design

Total Participants: 38
Treatment Group(s): 1
Primary Treatment: Lifespan Integration Therapy (LI)
Phase:
Study Start date:
April 01, 2024
Estimated Completion Date:
April 01, 2027

Connect with a study center

  • CHU St Anne

    Paris, Ile De France 75014
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.